Remove Big Data Remove Branding Remove Life Science Remove Marketing
article thumbnail

Revolutionizing Medicine and Public Health: The Emergence of Big Data in Healthcare

Roots Analysis

Big Data in healthcare refers to the vast amount of data that is continuously expanding and cannot be efficiently stored or processed using traditional tools. It accounts for the majority of big data in healthcare and comprises information, such as medical images, surveys, chats, and written narratives.

article thumbnail

SAVE THE DATE: PMN Fall 2021 Summit: Pharma-Marketing Innovations & Trends of 2021 – Sep. 16th

Pharma Marketing Network

SAVE THE DATE – PMN Fall 2021 Summit: Pharma-Marketing Innovations & Trends of 2021 | SEP. Pharmaceutical brands must adapt to this new modality and pivot their promotional efforts to ensure that they can leverage the Telehealth channel effectively. Marketing Agility – the Path to Digital Engagement & Innovation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

PMN Innovation Summit 2021

Pharma Marketing Network

Listen to how pharmaceutical brands and clinicians are adapting to this new modality and are pivoting their promotional efforts to ensure that they can leverage the Telehealth channel effectively. Panelists: Tim Glennon , Vice President of Marketing, Evofem Biosciences. Tres Garcia , Director Marketing, Agile Chapter Lead, Merck.

article thumbnail

PMN Innovation Summit 2021

Pharma Marketing Network

Listen to how pharmaceutical brands and clinicians are adapting to this new modality and are pivoting their promotional efforts to ensure that they can leverage the Telehealth channel effectively. Panelists: Tim Glennon , Vice President of Marketing, Evofem Biosciences. Tres Garcia , Director Marketing, Agile Chapter Lead, Merck.

article thumbnail

A history of AstraZeneca

pharmaphorum

German and Swiss pharma companies dominated the Swedish market at this time and it wasn’t until 1913 that the discussions were turned into a pharmaceutical company, Astra AB. Astra introduced two important product families onto the Swedish market in 1948: penicillin and anaesthetics, initially in the form of Xylocaine.